Similar articles for PMID: 28412732

Year	Number of Results
2000	1
2001	1
2002	2
2003	4
2004	1
2005	5
2006	16
2007	13
2008	31
2009	23
2010	25
2011	26
2012	39
2013	35
2014	22
2015	28
2016	33
2017	33
2018	35
2019	34
2020	40
2021	29
2022	11
2023	2
2024	0

1

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.

Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC. Weber H, et al. Oncotarget. 2017 Apr 18;8(16):26169-26184. doi: 10.18632/oncotarget.15410. Oncotarget. 2017. PMID: 28412732 Free PMC article.

2

Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.

Schwock J, Pham NA, Cao MP, Hedley DW. Schwock J, et al. Cancer Chemother Pharmacol. 2008 Apr;61(4):669-81. doi: 10.1007/s00280-007-0522-8. Epub 2007 Jun 20. Cancer Chemother Pharmacol. 2008. PMID: 17579866

3

Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis.

Watanabe G, Behrns KE, Kim JS, Kim RD. Watanabe G, et al. Cancer Chemother Pharmacol. 2009 Aug;64(3):433-43. doi: 10.1007/s00280-008-0888-2. Epub 2008 Dec 12. Cancer Chemother Pharmacol. 2009. PMID: 19082595 Free PMC article.

4

Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.

Sydor JR, Normant E, Pien CS, Porter JR, Ge J, Grenier L, Pak RH, Ali JA, Dembski MS, Hudak J, Patterson J, Penders C, Pink M, Read MA, Sang J, Woodward C, Zhang Y, Grayzel DS, Wright J, Barrett JA, Palombella VJ, Adams J, Tong JK. Sydor JR, et al. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17408-13. doi: 10.1073/pnas.0608372103. Epub 2006 Nov 7. Proc Natl Acad Sci U S A. 2006. PMID: 17090671 Free PMC article.

5

17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.

Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. Babchia N, et al. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2348-56. doi: 10.1167/iovs.07-1305. Epub 2008 Feb 15. Invest Ophthalmol Vis Sci. 2008. PMID: 18281615

6

SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers.

Chandarlapaty S, Sawai A, Ye Q, Scott A, Silinski M, Huang K, Fadden P, Partdrige J, Hall S, Steed P, Norton L, Rosen N, Solit DB. Chandarlapaty S, et al. Clin Cancer Res. 2008 Jan 1;14(1):240-8. doi: 10.1158/1078-0432.CCR-07-1667. Clin Cancer Res. 2008. PMID: 18172276 Free PMC article.

7

The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.

Georgakis GV, Li Y, Rassidakis GZ, Medeiros LJ, Younes A. Georgakis GV, et al. Exp Hematol. 2006 Dec;34(12):1670-9. doi: 10.1016/j.exphem.2006.07.002. Exp Hematol. 2006. PMID: 17157164 Free article.

8

Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.

Centenera MM, Gillis JL, Hanson AR, Jindal S, Taylor RA, Risbridger GP, Sutherland PD, Scher HI, Raj GV, Knudsen KE, Yeadon T; Australian Prostate Cancer BioResource; Tilley WD, Butler LM. Centenera MM, et al. Clin Cancer Res. 2012 Jul 1;18(13):3562-70. doi: 10.1158/1078-0432.CCR-12-0782. Epub 2012 May 9. Clin Cancer Res. 2012. PMID: 22573351

9

Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.

Ohba S, Hirose Y, Yoshida K, Yazaki T, Kawase T. Ohba S, et al. J Neurosurg. 2010 Jan;112(1):33-42. doi: 10.3171/2009.3.JNS081146. J Neurosurg. 2010. PMID: 19408974

10

Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.

Li YP, Chen JJ, Shen JJ, Cui J, Wu LZ, Wang Z, Li ZR. Li YP, et al. Cancer Chemother Pharmacol. 2015 Apr;75(4):773-82. doi: 10.1007/s00280-015-2696-9. Epub 2015 Feb 14. Cancer Chemother Pharmacol. 2015. PMID: 25681003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

429 results

Results by year